198 related articles for article (PubMed ID: 34560885)
1. Cerebrospinal fluid levels of the neurotrophic factor neuroleukin are increased in early Alzheimer's disease, but not in cerebral amyloid angiopathy.
De Kort AM; Kuiperij HB; Alcolea D; Kersten I; Versleijen AAM; Greenberg SM; Stoops E; Schreuder FHBM; Klijn CJM; Lleó A; Claassen JAHR; Verbeek MM
Alzheimers Res Ther; 2021 Sep; 13(1):160. PubMed ID: 34560885
[TBL] [Abstract][Full Text] [Related]
2. Normal cerebrospinal fluid concentrations of PDGFRβ in patients with cerebral amyloid angiopathy and Alzheimer's disease.
De Kort AM; Kuiperij HB; Kersten I; Versleijen AAM; Schreuder FHBM; Van Nostrand WE; Greenberg SM; Klijn CJM; Claassen JAHR; Verbeek MM
Alzheimers Dement; 2022 Oct; 18(10):1788-1796. PubMed ID: 34874603
[TBL] [Abstract][Full Text] [Related]
3. Cerebrospinal Fluid Alzheimer's Disease Biomarkers in Cerebral Amyloid Angiopathy-Related Inflammation.
Renard D; Wacongne A; Ayrignac X; Charif M; Fourcade G; Azakri S; Le Floch A; Bouly S; Marelli C; Arquizan C; Hirtz C; Gabelle A; Thouvenot E; Lehmann S
J Alzheimers Dis; 2016; 50(3):759-764. PubMed ID: 26757185
[TBL] [Abstract][Full Text] [Related]
4. Cerebrospinal Fluid Panel of Synaptic Proteins in Cerebral Amyloid Angiopathy and Alzheimer's Disease.
van den Berg E; Nilsson J; Kersten I; Brinkmalm G; de Kort AM; Klijn CJM; Schreuder FHBM; Jäkel L; Gobom J; Portelius E; Zetterberg H; Brinkmalm A; Blennow K; Kuiperij HB; Verbeek MM
J Alzheimers Dis; 2023; 92(2):467-475. PubMed ID: 36776062
[TBL] [Abstract][Full Text] [Related]
5. Comparison of cerebrospinal fluid profiles in Alzheimer's disease with multiple cerebral microbleeds and cerebral amyloid angiopathy-related inflammation.
Kimura A; Takemura M; Saito K; Yoshikura N; Hayashi Y; Harada N; Nishida H; Nakajima H; Inuzuka T
J Neurol; 2017 Feb; 264(2):373-381. PubMed ID: 28000005
[TBL] [Abstract][Full Text] [Related]
6. Comorbid cerebral amyloid angiopathy in dementia and prodromal stages-Prevalence and effects on cognition.
Haussmann R; Homeyer P; Sauer C; Grey A; Krukowski P; Brandt MD; Donix M; Linn J
Int J Geriatr Psychiatry; 2023 Oct; 38(10):e6015. PubMed ID: 37847104
[TBL] [Abstract][Full Text] [Related]
7. Cerebral Amyloid Angiopathy-Related Microbleeds and Cerebrospinal Fluid Biomarkers in Alzheimer's Disease.
Noguchi-Shinohara M; Komatsu J; Samuraki M; Matsunari I; Ikeda T; Sakai K; Hamaguchi T; Ono K; Nakamura H; Yamada M
J Alzheimers Dis; 2017; 55(3):905-913. PubMed ID: 27802236
[TBL] [Abstract][Full Text] [Related]
8. Cerebrospinal fluid metallomics in cerebral amyloid angiopathy: an exploratory analysis.
Banerjee G; Forsgard N; Ambler G; Keshavan A; Paterson RW; Foiani MS; Toombs J; Heslegrave A; Thompson EJ; Lunn MP; Fox NC; Zetterberg H; Schott JM; Werring DJ
J Neurol; 2022 Mar; 269(3):1470-1475. PubMed ID: 34292397
[TBL] [Abstract][Full Text] [Related]
9. Cerebrospinal Fluid Levels of Amyloid Beta 1-43 in Patients with Amnestic Mild Cognitive Impairment or Early Alzheimer's Disease: A 2-Year Follow-Up Study.
Lauridsen C; Sando SB; Shabnam A; Møller I; Berge G; Grøntvedt GR; Bakken IJ; Salvesen Ø; Bråthen G; White LR
Front Aging Neurosci; 2016; 8():30. PubMed ID: 26973507
[TBL] [Abstract][Full Text] [Related]
10. Cerebrospinal Fluid Biomarkers in Cerebral Amyloid Angiopathy.
Banerjee G; Ambler G; Keshavan A; Paterson RW; Foiani MS; Toombs J; Heslegrave A; Dickson JC; Fraioli F; Groves AM; Lunn MP; Fox NC; Zetterberg H; Schott JM; Werring DJ
J Alzheimers Dis; 2020; 74(4):1189-1201. PubMed ID: 32176643
[TBL] [Abstract][Full Text] [Related]
11. Cerebrospinal Fluid Biomarkers and Amyloid-β Elimination from the Brain in Cerebral Amyloid Angiopathy-Related Inflammation.
Sakai K; Noguchi-Shinohara M; Tanaka H; Ikeda T; Hamaguchi T; Kakita A; Yamada M; Ono K
J Alzheimers Dis; 2023; 91(3):1173-1183. PubMed ID: 36565118
[TBL] [Abstract][Full Text] [Related]
12. Relationship between β-Secretase, inflammation and core cerebrospinal fluid biomarkers for Alzheimer's disease.
Alcolea D; Carmona-Iragui M; Suárez-Calvet M; Sánchez-Saudinós MB; Sala I; Antón-Aguirre S; Blesa R; Clarimón J; Fortea J; Lleó A
J Alzheimers Dis; 2014; 42(1):157-67. PubMed ID: 24820015
[TBL] [Abstract][Full Text] [Related]
13. Apolipoprotein D: a potential biomarker for cerebral amyloid angiopathy.
Kuiperij HB; Hondius DC; Kersten I; Versleijen AAM; Rozemuller AJM; Greenberg SM; Schreuder FHBM; Klijn CJM; Verbeek MM
Neuropathol Appl Neurobiol; 2020 Aug; 46(5):431-440. PubMed ID: 31872472
[TBL] [Abstract][Full Text] [Related]
14. Cerebral Amyloid Angiopathy in Amyloid-Positive Patients from a Memory Clinic Cohort.
Costa AS; Pinho J; Kučikienė D; Reich A; Schulz JB; Reetz K
J Alzheimers Dis; 2021; 79(4):1661-1672. PubMed ID: 33492291
[TBL] [Abstract][Full Text] [Related]
15. Aβ38 and Aβ43 do not differentiate between Alzheimer's disease and cerebral amyloid angiopathy.
Dargvainiene J; Jensen-Kondering U; Bender B; Berg D; Brüggemann N; Flüh C; Markewitz R; Neumann A; Röben B; Röcken C; Royl G; Schulte C; Wandinger KP; Weiler C; Margraf NG; Kuhlenbäumer G
Ann Clin Transl Neurol; 2024 Mar; 11(3):806-811. PubMed ID: 38186185
[TBL] [Abstract][Full Text] [Related]
16. YKL-40 changes are not detected in post-mortem brain of patients with Alzheimer's disease and frontotemporal lobar degeneration.
Hok-A-Hin YS; Hoozemans JJM; Hu WT; Wouters D; Howell JC; Rábano A; van der Flier WM; Pijnenburg YAL; Teunissen CE; Del Campo M
Alzheimers Res Ther; 2022 Jul; 14(1):100. PubMed ID: 35879733
[TBL] [Abstract][Full Text] [Related]
17. Decreased Cerebrospinal Fluid Amyloid β 38, 40, 42, and 43 Levels in Sporadic and Hereditary Cerebral Amyloid Angiopathy.
De Kort AM; Kuiperij HB; Marques TM; Jäkel L; van den Berg E; Kersten I; van Berckel-Smit HEP; Duering M; Stoops E; Abdo WF; Rasing I; Voigt S; Koemans EA; Kaushik K; Warren AD; Greenberg SM; Brinkmalm G; Terwindt GM; Wermer MJH; Schreuder FHBM; Klijn CJM; Verbeek MM
Ann Neurol; 2023 Jun; 93(6):1173-1186. PubMed ID: 36707720
[TBL] [Abstract][Full Text] [Related]
18. Profiling amyloid-β peptides as biomarkers for cerebral amyloid angiopathy.
van den Berg E; Kersten I; Brinkmalm G; Johansson K; de Kort AM; Klijn CJM; Schreuder FHBM; Gobom J; Stoops E; Portelius E; Gkanatsiou E; Zetterberg H; Blennow K; Kuiperij HB; Verbeek MM
J Neurochem; 2024 Feb; ():. PubMed ID: 38362804
[TBL] [Abstract][Full Text] [Related]
19. Cerebral amyloid angiopathy in Down syndrome and sporadic and autosomal-dominant Alzheimer's disease.
Carmona-Iragui M; Balasa M; Benejam B; Alcolea D; Fernández S; Videla L; Sala I; Sánchez-Saudinós MB; Morenas-Rodriguez E; Ribosa-Nogué R; Illán-Gala I; Gonzalez-Ortiz S; Clarimón J; Schmitt F; Powell DK; Bosch B; Lladó A; Rafii MS; Head E; Molinuevo JL; Blesa R; Videla S; Lleó A; Sánchez-Valle R; Fortea J
Alzheimers Dement; 2017 Nov; 13(11):1251-1260. PubMed ID: 28463681
[TBL] [Abstract][Full Text] [Related]
20. Cerebrospinal fluid biomarkers for cerebral amyloid angiopathy.
Sembill JA; Lusse C; Linnerbauer M; Sprügel MI; Mrochen A; Knott M; Engelhorn T; Schmidt MA; Doerfler A; Oberstein TJ; Maler JM; Kornhuber J; Lewczuk P; Rothhammer V; Schwab S; Kuramatsu JB
Brain Commun; 2023; 5(3):fcad159. PubMed ID: 37389304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
